What is she best known for?
The fields of study she is best known for:
- Neuroscience
- Serotonin
- Neuron
The scientist’s investigation covers issues in Neuroscience, Serotonin, Serotonergic, Receptor and 5-HT receptor.
Her work on Neuroglia and Hippocampus as part of general Neuroscience research is frequently linked to Cellular localization, thereby connecting diverse disciplines of science.
Her research brings together the fields of Neurotransmitter and Serotonin.
Patricia M. Whitaker-Azmitia combines subjects such as Agonist and Forebrain with her study of Neurotransmitter.
Her Serotonergic study improves the overall literature in Internal medicine.
Her research integrates issues of Stimulation and Astrocyte in her study of Receptor.
Her most cited work include:
- Serotonin and brain development: role in human developmental diseases (395 citations)
- Serotonin as a developmental signal. (323 citations)
- Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. (297 citations)
What are the main themes of her work throughout her whole career to date?
Patricia M. Whitaker-Azmitia focuses on Neuroscience, Serotonin, Endocrinology, Internal medicine and Serotonergic.
Her Neuroscience study incorporates themes from Neuropeptide, Receptor and Growth factor.
Her biological study spans a wide range of topics, including Synaptogenesis, Pharmacology, Neurotransmitter and Nerve growth factor.
In her study, which falls under the umbrella issue of Endocrinology, 5-HT1A receptor is strongly linked to Agonist.
Her study on Fenfluramine, 5-HT3 receptor, Oxytocin and Senescence is often connected to Microtubule-associated protein as part of broader study in Internal medicine.
Her study in the fields of Raphe under the domain of Serotonergic overlaps with other disciplines such as Plasticity.
She most often published in these fields:
- Neuroscience (60.00%)
- Serotonin (48.57%)
- Endocrinology (47.14%)
What were the highlights of her more recent work (between 2001-2017)?
- Neuroscience (60.00%)
- Serotonergic (42.86%)
- Internal medicine (47.14%)
In recent papers she was focusing on the following fields of study:
Patricia M. Whitaker-Azmitia mainly investigates Neuroscience, Serotonergic, Internal medicine, Endocrinology and Serotonin.
The Neurotransmitter, Thalamus, Somatosensory system and Neurogenesis research Patricia M. Whitaker-Azmitia does as part of her general Neuroscience study is frequently linked to other disciplines of science, such as White matter, therefore creating a link between diverse domains of science.
Her Hippocampus research extends to the thematically linked field of Serotonergic.
Her research integrates issues of Synaptogenesis and Pathology in her study of Internal medicine.
Her research is interdisciplinary, bridging the disciplines of Autism and Serotonin.
In her work, Agonist, Raphe nuclei, 5-HT receptor and Serotonin Agonist is strongly intertwined with Central nucleus of the amygdala, which is a subfield of Autism.
Between 2001 and 2017, her most popular works were:
- Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? (230 citations)
- Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. (76 citations)
- Origin, migration and fate of newly generated neurons in the adult rodent piriform cortex. (67 citations)
In her most recent research, the most cited papers focused on:
- Neuron
- Internal medicine
- Neurotransmitter
Her main research concerns Neuroscience, Serotonergic, Autism, Amygdala and Serotonin.
Her work on Neuroscience is being expanded to include thematically relevant topics such as Pervasive developmental disorder.
Her Serotonergic study frequently involves adjacent topics like Neurochemical.
Internal medicine and Endocrinology are the focus of her Amygdala studies.
Her research links Agonist with Serotonin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
